Diagnostic Value of Systematic Biopsy Methods in the Investigation of Prostate Cancer: A Systematic Review

Journal of Urology

Volumn 175, Issue 5, 2006, Pages 1605-1612

  Eichler, Klaus ^a   Hempel, Susanne ^a   Wilby, Jennifer ^a   Myers, Lindsey ^a   Bachmann, Lucas M ^a   Kleijnen, Jos ^a  

^a UNIVERSITY OF ZURICH   (Switzerland)

Author keywords

biopsy; prostate; prostatic neoplasms

Indexed keywords

BLEEDING; CANCER CYTODIAGNOSIS; CANCER EPIDEMIOLOGY; CANCER LOCALIZATION; CANCER PATIENT; CANCER SCREENING; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; HEMATURIA; HEMOSPERMIA; HISTOPATHOLOGY; HUMAN; INFECTION; MEDICAL EXPERT; MEDICAL LITERATURE; MICTURITION DISORDER; PRIORITY JOURNAL; PROSTATE BIOPSY; PROSTATE CANCER; RECTUM HEMORRHAGE; REFERENCE DATABASE; REVIEW; SAMPLE SIZE; STATISTICAL ANALYSIS; SYSTEMATIC REVIEW; TISSUE SECTION;

BIOPSY; HUMANS; MALE; PROSTATIC NEOPLASMS; REPRODUCIBILITY OF RESULTS;

EID: 33646489152     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-5347(05)00957-2     Document Type: Review

References (42)

1. Hodge K.K., McNeal J.E., Terris M.K., and Stamey T.A. Random systematic versus directed ultrasound guided transrectal core biopsies of the prostate. J Urol 142 (1989) 71
2. Norberg M., Egevad L., Holmberg L., Sparen P., Norlen B.J., and Busch C. The sextant protocol for ultrasound-guided core biopsies of the prostate underestimates the presence of cancer. Urology 50 (1997) 562
3. Presti Jr. J.C., Chang J.J., Bhargava V., and Shinohara K. The optimal systematic prostate biopsy scheme should include 8 rather than 6 biopsies. results of a prospective clinical trial. J Urol 163 (2000) 163
4. Davis M., Sofer M., Kim S.S., and Soloway M.S. The procedure of transrectal ultrasound guided biopsy of the prostate. a survey of patient preparation and biopsy technique. J Urol 167 (2002) 566
5. Patel H.R., Lee F., Arya M., Masood S., Palmer J.H., and Sheriff M.K.M. A national survey of transrectal ultrasound-guided prostatic biopsies. time for a national guideline. Int J Clin Pract 57 (2003) 773
6. CRD's Guidance for Those Carrying Out or Commissioning Reviews. NHS Centre for Reviews and Dissemination (2001), University of York, York, United Kingdom
7. Irwig L., Tosteson A.N., Gatsonis C., Lau J., Colditz G., Chalmers T.C., et al. Guidelines for meta-analyses evaluating diagnostic tests. Ann Intern Med 120 (1994) 667
8. Deeks J.J. Systematic reviews in health care. systematic reviews of evaluations of diagnostic and screening tests. BMJ 323 (2001) 157
9. Irwig L., Macaskill P., Glasziou P., and Fahey M. Meta-analytic methods for diagnostic test accuracy. J Clin Epidemiol 48 (1995) 119
10. Eskew L.A., Bare R.L., and McCullough D.L. Systematic 5 region prostate biopsy is superior to sextant method for diagnosing carcinoma of the prostate. J Urol 157 (1997) 199
11. Babaian R.J., Toi A., Kamoi K., Troncoso P., Sweet J., Evans R., et al. A comparative analysis of sextant and an extended 11-core multisite directed biopsy strategy. J Urol 163 (2000) 152
12. Whiting P., Rutjes A.W., Dinnes J., Reitsma J., Bossuyt P.M., and Kleijnen J. Development and validation of methods for assessing the quality of diagnostic accuracy studies. Health Technol Assess 8 (2004) 1
13. Deeks J.J. Issues in the selection of a summary statistic for meta-analysis of clinical trials with binary outcomes. Stat Med 21 (2002) 1575
14. Higgins J.P., Thompson S.G., Deeks J.J., and Altman D.G. Measuring inconsistency in meta-analyses. BMJ 327 (2003) 557
15. Vashi A.R., Wojno K.J., Gillespie B., and Oesterling J.E. A model for the number of cores per prostate biopsy based on patient age and prostate gland volume. J Urol 159 (1998) 920
16. Balbontín F., Bermúdez H., Meneses M., and Covarrubias A. Seis versus doce biopsias ecoguiadas en el diagnóstico de cancer de próstata. Rev Chil Urol 65 (2000) 234
17. de la Taille A., Antiphon P., Salomon L., Cherfan M., Porcher R., Hoznek A., et al. Prospective evaluation of a 21-sample needle biopsy procedure designed to improve the prostate cancer detection rate. Urology 61 (2003) 1181
18. Emiliozzi P., Corsetti A., Tassi B., Federico G., Martini M., and Pansadoro V. Best approach for prostate cancer detection. a prospective study on transperineal versus transrectal six-core prostate biopsy. Urology 61 (2003) 961
19. Gore J.L., Shariat S.F., Miles B.J., Kadmon D., Jiang N., Wheeler T.M., et al. Optimal combinations of systematic sextant and laterally directed biopsies for the detection of prostate cancer. J Urol 165 (2001) 1554
20. Ito K., Ohi M., Yamamoto T., Miyamoto S., Kurokawa K., Fukabori Y., et al. The diagnostic accuracy of the age-adjusted and prostate volume-adjusted biopsy method in males with prostate specific antigen levels of 4.1-10.0 ng/mL. Cancer 95 (2002) 2112
21. Kawakami S., Koga F., Yano A., Ohtsuka Y., Saito K., Yano M., et al. 22-Core systematic biopsy (transperineal-14 plus transrectal-8 cores) remarkably improves prostate cancer detection over conventional sextant biopsy. J Urol 169 suppl. (2003) 435 abstract 1627
22. Kravchick S., Cytron S., Peled R., London D., Sibi Y., and Ben-Dor D. Optimal combinations for detection of prostate cancer. systematic sextant and laterally directed biopsies versus systematic sextant and color Doppler-targeted biopsies. Urology 63 (2004) 301
23. Meng M.V., Franks J.H., Presti Jr. J.C., and Shinohara K. The utility of apical anterior horn biopsies in prostate cancer detection. Urol Oncol 21 (2003) 361
24. Naughton C.K., Miller D.C., Mager D.E., Ornstein D.K., and Catalona W.J. A prospective randomized trial comparing 6 versus 12 prostate biopsy cores. impact on cancer detection. J Urol 164 (2000) 388
25. Pepe P., Leanza F.G., Panella P., Savoca F., D'Arrigo L., Gulletta M., et al. La biopsia prostatica ecoguidata: influenza del numero dei prelievi sulla 'detection rate' del carcinoma prostatico. Valutazione della nostra esperienza in 946 pazienti. Internista 10 (2002) 160
26. Philip J., Ragavan N., Desouza J., Foster C.S., and Javle P. Effect of peripheral biopsies in maximising early prostate cancer detection in 8-, 10- or 12-core biopsy regimens. BJU Int 93 (2004) 1218
27. Rowe E., Patel A., Hunter M., and Walker M. Prostate cancer detection rates in lateral versus medial cores when adopting a 12 core biopsy strategy in prostates larger than 40 cc. Eur Urol Suppl 1 (2002) 164
28. Singh H., Canto E.I., Shariat S.F., Kadmon D., Miles B.J., and Slawin K.M. Systematic 12-core biopsy degrades performance of percent free PSA and PSA density for prostate cancer detection. J Urol 169 suppl. (2003) 428 abstract 1604
29. Slongo L.E., Sugisawa M.C., Ioshii S.O., Filho R.T., and Rocha L.C. Efficiency of 6- and 12-punctures biopsies to detect prostate cancer in patients with PSA
30. Terris M.K., Wallen E.M., and Stamey T.A. Comparison of mid-lobe versus lateral systematic sextant biopsies in the detection of prostate cancer. Urol Int 59 (1997) 239
31. Emiliozzi P., Scarpone P., DePaula F., Pizzo M., Federico G., Pansadoro A., et al. The incidence of prostate cancer in men with prostate specific antigen greater than 4.0 ng/ml. a randomized study of 6 versus 12 core transperineal prostate biopsy. J Urol 171 (2004) 197
32. Horninger W., Reissigl A., Fink K., Pointner J., Strasser H., and Bartsch G. Results of a prospective randomized study comparing the prostate cancer detection rates in PSA screening volunteers undergoing 10 vs. 14 transrectal ultrasound guided biopsies. J Urol 159 suppl. (1998) 180 abstract 690
33. Paul R., Schöler S., Alschibaja M., Kübler H., van Randenborgh H., and Hartung R. 6 Vs. 10-core prostatic biopsy-results of a prospective, randomised trial. Eur Urol Suppl 2 (2003) 108
34. Iczkowski K.A., Casella G., Seppala R.J., Jones G.L., Mishler B.A., Qian J., et al. Needle core length in sextant biopsy influences prostate cancer detection rate. Urology 59 (2002) 698
35. Presti Jr. J.C. Prostate biopsy. how many cores are enough?. Urol Oncol 21 (2003) 135
36. Terris M.K. Extended field prostate biopsies. too much of a good thing?. Urology 55 (2000) 457
37. Van der Kwast T.H., Lopes C., Martikainen P.M., Pihl C.G., Santonja C., Neetens I., et al. Report of the Pathology Committee. false-positive and false-negative diagnoses of prostate cancer. BJU Int 92 suppl (2003) 62
38. Schroder F.H., Denis L.J., Roobol M., Nelen V., Aurinen A., Tammela T., et al. The story of the European Randomized Study of screening for prostate cancer. BJU Int 92 suppl. (2003) 1
39. Donovan J., Hamdy F., Neal D., Peters T., Oliver S., Brindle L., et al. Prostate testing for cancer and treatment (ProtecT) feasibility study. Health Technol Assess 7 (2003) 1
40. Paul R., Scholer S., van Randenborgh H., Kubler H., Alschibaja M., Busch R., et al. Morbidity of prostatic biopsy for different biopsy strategies. Is there a relation to core number and sampling region?. Eur Urol 45 (2004) 450
41. Naughton C.K., Ornstein D.K., Smith D.S., and Catalona W.J. Pain and morbidity of transrectal ultrasound guided prostate biopsy. a prospective randomized trial of 6 versus 12 cores. J Urol 163 (2000) 168
42. Naughton C.K., Miller D.C., and Yan Y. Impact of transrectal ultrasound guided prostate biopsy on quality of life. a prospective randomized trial comparing 6 versus 12 cores. J Urol 165 (2001) 100